Sony T
AI is mostly established as a catch-all phrase to describe the coming technology, but its operation and applications are much more discrete as mentioned. The availed situations are expanding from customer service support, to online advertising, to smart home applications, self-driving cars, drones and many more.Yet, some of the astonishing functions are developed and formulated in healthcare and medicine. AI is meant not only to lend a hand for scientists and researchers to find cures through protein-folding to beat cancer or enabling gene editing through CRISPR models, but also for encouraging the requirement for early disease detection, that is very necessary in preventive treatment.
Artificial Intelligence is functionally developed to detect early stage cancer symptoms, more accurately than conventional methods such as human doctors peering over MRI scans and X-Rays, keeping an eye for anomalies. Machine-learning models and neural networks can also support AI to detect such anomalies in a fraction of the time taken by doctors. This is especially meant for the benefaction in the Indian market, provided the breadth of its population and the lack of intensive diagnostics in many remote areas.
India has less than 10K radiologists with more than a billion people in the country. The skewed radiologists to patient ratio of 1:100K summons to early and timely disease detection and hence, is definitely a major challenge in the Indian healthcare market.
Detecting diseases quickly and efficiently is not just essential for cancer and heart diseases, but also for infectious diseases like tuberculosis, or hidden injuries like brain trauma and other disorders that demand special medical imaging. The device confirmed cannot just virtually influence the speed and efficiency of disease detection, it can also free up doctors to produce other interventions, instead of spending weeks studying reports and vitals.
Mumbai-based Qure.ai is aiming to accomplish the development by minimising that gap by involving AI and deep learning technology to studying radiology images for quick and accurate diagnosis of diseases. The startup further claims that its algorithms can detect clinically relevant abnormal trauma findings from X-rays, CT Scans and MRIs in a fraction of the time that doctors typically take.
The company also claims to confirm more than 7 Mn data sets to train its AI algorithms, and has also validated test results and accuracy of its diagnosis at global institutions such as Stanford University, the Mayo Clinic, and the Massachusetts General Hospital.
